Consolidated Statements of Cash Flows - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2018	Jun. 30, 2017
Cash Flows From Operating Activities:
Net loss	$ (7,511,092)	$ (9,449,295)	$ (14,891,050)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	745,741	234,510	1,700,225
Stock issued for services			56,160
Change in fair value of derivative instruments-warrants	(1,062,769)	(5,322,362)	(4,224,819)
Change in fair value of contingent consideration		265,398
Change in the fair value of debt		108,942
Deferred tax liability adjustment	(372,920)	(536,000)
Loss on the sale of assets		4,474
Depreciation and amortization expense	10,969	18,787	27,993
Changes in operating assets and liabilities:
Accounts payable and accrued expense	(111,207)	(897,695)	(2,128,263)
Deferred rent liability		9,235
Prepaid expenses and other assets	91,992	(82,021)	287,644
Net Cash used in Operating Activities	(8,209,286)	(15,646,027)	(19,172,110)
Cash Flows From Investing Activities:
Proceeds from sale of fixed asset		900
Purchases of property and equipment			(14,709)
Net Cash Provided by (Used in) Investing Activities		900	(14,709)
Cash Flows From Financing Activities:
Change in current portion of capital lease			(10,410)
Proceeds from the issuance of common stock	1,180,555	1,635,140	24,659,760
Proceeds from issuance of Series C Preferred stock, net		10,414,741
Proceeds from the exercise of warrants		142,600	85,000
Proceeds from stock options exercised			31,277
Proceeds from debt financing		2,000,000
Repayment of debt financing		(668,942)
Payment of contingent consideration milestone		(1,000,000)
Net cash provided by Financing Activities	1,180,555	12,523,539	24,765,627
Net (decrease) increase in cash	(7,028,731)	(3,121,588)	5,578,808
Cash at beginning of period	12,982,748	5,954,017	7,403,940
Cash at end of period	5,954,017	2,832,429	12,982,748
Supplementary Disclosure Of Cash Flow Information:
Cash paid for interest		131,058
Supplementary Disclosure Of Non-Cash Financing Activities:
Stock issued to employees in lieu of cash payment for accrued bonus	$ 230,086	296,037
Issuance of common stock in conjunction with milestone payment		55,398
Derecognition of Series C warrants exercised		34,136	75,417
Fair value of warrants issued in conjunction with common stock offering		5,091,373	$ 3,976,501
Warrants issued to placement agent		221,269
Series A convertible preferred stock
Supplementary Disclosure Of Non-Cash Financing Activities:
Conversion of convertible preferred stock		184,320
Series C convertible preferred stock
Supplementary Disclosure Of Non-Cash Financing Activities:
Conversion of convertible preferred stock		4,680,212
Beneficial Conversion Factor accreted as Series C dividend		$ 3,771,639